SECOND QUARTER 2025 EARNINGS Our AI business continues to scale, with four new NPU agreements signed during the quarter - marking a pivotal moment in customer adoption and underscoring the growing demand for our industry-leading edge AI technologies. Amir Panush, CEO T O T A L R E V E N U E E A R N I N G S P E R S H A R E Q U A R T E R L Y R E V E N U E S $25.7M 7¢ NON-GAAP versus 17¢ In Q2'24 (15¢) versus $28.4 million in Q2'24 GAAP versus (1¢) in Q2'24 Q U A R T E R L Y P E R F O R M A N C E O V E R V I E ...

Kymera Therapeutics Second Quarter 2025 Quarterly Results Call August 11, 2025 Agenda Introduction Bruce Jacobs, CFA, MBA, Chief Financial Officer Key Highlights and Business Update Nello Mainolfi, PhD, Founder, President and Chief Executive Officer Clinical Update Jared Gollob, MD, Chief Medical Officer Financial Review Bruce Jacobs, CFA, MBA, Chief Financial Officer Question and Answer Session VISION EXECUTION IMPACT • Delivered 5 new investigational degrader drugs into the clinic since 2020, and on path ...

Q1 FY26 Results & Operational Highlights August 2025 Important Disclaimers The contents of this presentation are not to be construed as legal, regulatory, business, accounting or tax advice. You should consult your own attorney, business advisor, accountant and tax advisor as to legal, regulatory, business, accounting and tax advice. This presentation has been prepared exclusively for the internal confidential use of the recipient only. This presentation is confidential. Any reproduction of distribution of ...

Second Quarter 2025 Continuing Operations Supplemental Earnings Slides August 11, 2025 1 Confidential & Proprietary to Owens & Minor, Inc. The non-GAAP financial measures disclosed by the Company should not be considered substitutes for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated. Safe Harbor 2 Confidential & Proprietary to O ...

Q2 FY25 Financial Highlights - Revenue reached $299 million, representing a 27% year-over-year growth[5] - The company saw a 36% year-over-year increase in customers with ARR (Annual Recurring Revenue) exceeding $50,000, totaling 3,702 customers[5] - Net dollar retention rate for customers with ARR over $50,000 was 116%[5] - Gross margin stood strong at 90%[5] - Adjusted free cash flow was $64 million, which is 21% of the revenue[5] Customer Base Growth - Total customers increased to 245,000 in FY24[16], reflecting a 22% CAGR (Compound Annual Growth Rate) from 2019 to 2024[17, 18] - Customers with ARR over $50,000 grew by 36% year-over-year[25] - Customers with ARR exceeding $100,000 also increased, showing a 46% year-over-year growth[25] Revenue and ARR Trends - The trend shows an increasing percentage of total ARR coming from larger customers, with those having over $100,000 ARR accounting for 38% of the total[28] - Customers with over $50,000 ARR contribute 26% to the total ARR[28] - Customers with more than 10 users account for 80% of the total ARR[28] Financial Performance - The company has demonstrated consistent incremental revenue growth, as shown by the increase from $161 million in FY20 to $972 million in FY24[35] - The annual revenue shows a CAGR of 57% from 2020 to 2024[35] - Adjusted free cash flow for Q2 2025 was $641 million, representing 21% of revenue[5, 47]

Transaction Overview - Western Union will acquire International Money Express for $1600 per share in cash[16] - The transaction is expected to close in mid-2026, pending regulatory approvals and closing conditions[18] - The acquisition is expected to yield $30 million in annual run-rate cost synergies within 24 months[16] - The transaction is expected to be immediately EPS-accretive[17] Strategic Benefits - The acquisition increases scale in high-growth LACA geographies through complementary agent networks[17] - It expands and stabilizes Western Union's U S retail footprint, enhancing resilience and improving customer access across the Americas[17] - The combined company is projected to have approximately 70000 send locations[25] - The combined company is projected to have approximately 21 million customers[25] - The combined company is projected to have approximately $2100 million in revenue[25] Financial Impact - The transaction is expected to drive an incremental $010 of Adjusted EPS in the first full year[31] - The acquisition strengthens long-term Free Cash Conversion[35]

August 11, 2025 Second Quarter 2025 Financial Results & Corporate Update This presentation is for investor relations purposes only - Not for product promotional purposes 1 Agenda | 1 | Opening Remarks | | --- | --- | | 2 | Q2 2025 Highlights & Recent Accomplishments | | 3 | Our Pipeline | | 4 | Capitalizing on Market Leadership | | 5 | CARVYKTI® Performance Overview | | 6 | Financial Performance | | 7 | Q&A | 2 This presentation is for investor relations purposes only - Not for product promotional purposes ...

Financial Performance - Q2 2025 revenue was $20.5 million, compared to $23.1 million in Q2 2024[6] - Gross margin in Q2 2025 was 56.4%, compared to 57.2% in Q2 2024[6] - Adjusted EBITDA for Q2 2025 was $1.5 million, compared to $1.3 million in Q2 2024[6] - Q3 2025 revenue is projected to be in the range of $19 million to $21 million[16] - Q3 2025 gross margin is projected to be in the range of 56% to 58%[16] Regional Performance - APAC region experienced a 25.4% year-over-year decrease in Q2 2025, but with a 1.1% increase from F/X[7] - EMEA region was relatively flat, with a 0.3% year-over-year decrease in Q2 2025, but with a 5.0% increase from F/X[7] - US Pre-Clinical declined 11.7% year-over-year in Q2 2025[7] Strategic Focus - The company is prioritizing stabilizing the core business and restructuring the balance sheet to build sustainable sales and profitability[19] - The company is positioning the business for renewed growth and margin expansion in 2026 and beyond[19] - The company is focused on accelerating product adoption by leveraging a strong and innovative pipeline[19]

Company Overview - NIU was founded in 2014[3] - The company has 4,304 stores in China[3] - NIU products are sold in 53 countries[3,29] - The company has sold 5.7 million scooters globally[3] Sales Performance (Q2 2025) - China sales volume reached 319,000 units, a 54% year-over-year increase[41] - Overseas sales volume reached 33,000 units, a 36% year-over-year decrease[41] - Total revenue was RMB 1,256 million, a 34% year-over-year increase[41] Financial Metrics (Q2 2025) - Gross margin was 20.1% of revenues[45] - Adjusted operating expenses were 17.0% of revenues[45] - Net margin was -27.2%[50] - Adjusted net margin was -2.1%[53] Balance Sheet (June 30, 2025) - Cash, restricted cash, deposits & short-term investment totaled RMB 1,441 million[48] - Total assets amounted to RMB 3,094 million[48] - Total liabilities amounted to RMB 2,190 million[48]

DEC: The Only Publicly Traded Champion of the PDP Subsector Energy Second Quarter Results Presentation August 11, 2025 Optimized The information contained in this document (the "Presentation") has been prepared by Diversified Energy Company PLC ("Diversified" or the "Company"). This Presentation is for general information purposes only and does not constitute an invitation or inducement to any person to engage in investment activity. While the information contained herein has been prepared in good faith, ne ...